- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03861026
Cerebral Oximetry to Reduce Organ Dysfunction After Non-cardiac Surgery
Role of Cerebral Oximetry In Reducing Postoperative End Organ Dysfunction/Failure After Complex Non- Cardiac Surgery
Number of elderly patients requiring general anesthesia for major surgical procedures is increasing dramatically. It is estimated that 20% of these patients will develop major complications after surgery. Monitoring brain oxygen saturation may be helpful in reducing the postoperative complication rates. A decrease in brain oxygen is a sign that all other vital organs such as kidneys, heart, liver, and intestines have reduced blood supply and are starved from oxygen. This happens in 1 out of 5 patients undergoing major complex surgeries. Brain oxygen saturation monitor at this time is not used routinely during surgery, primarily due to the added cost, as well as, insufficient evidence that restoring the brain oxygen saturation to baseline would result in better outcomes. Patients will be randomly assigned to either study or control groups. In the study group, a special algorithm will be used to restore brain oxygen saturation. In the control group, the brain oxygen saturation will be monitored continuously, but the monitor screen will be electronically blinded, and standard clinical care applied. The objective of this study is to see if restoring the brain oxygen saturation to baseline results in less complication rates after surgery.
The objective of this study is to reduce the incidence of postoperative morbidity due to end organ dysfunction after major non-cardiac surgery in elderly patients.
The primary aim is to determine if restoration of rSO2 to baseline levels results in reduced incidence of major organ morbidity and mortality (MOMM).
A secondary aim is to determine a cost-effectiveness of this monitoring modality.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: George Djaiani
- Telefoonnummer: 6205 416-340-4800
- E-mail: george.djaiani@uhn.ca
Studie Contact Back-up
- Naam: JO Carroll
- Telefoonnummer: 3243 146-340-4800
- E-mail: jo.carroll@uhn.ca
Studie Locaties
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 2C4
- Werving
- Tornoto General Hospital, University Health Network
-
Contact:
- Keyvan Karkouti, MD
- Telefoonnummer: 8597 416-340-4800
- E-mail: Keyvan.Karkouti@uhn.ca
-
Onderonderzoeker:
- W. Scott Beattie, MD
-
Onderonderzoeker:
- Vivek Rao, MD
-
Onderonderzoeker:
- Rita Katznelson, MD
-
Onderonderzoeker:
- Marcin Wasowicz, MD
-
Onderonderzoeker:
- Martin Lenihan, MD
-
Onderonderzoeker:
- Rima Styra, MD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Patients > 60 years of age
- Undergoing elective major non-cardiac surgery with an anticipated surgical duration of 4 hours or more,
- Preoperative written informed consent.
Exclusion Criteria:
- Emergency surgery
- Laparoscopic/Robotic surgery
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Intervention group
Bilateral NIRS (Masimo, O3TM Regional Oximetry) will be used to measure rSO2 intraoperatively. In the interventional group, an alarm threshold at 90% of the baseline rSO2 value will be established. Based on predetermined algorithm the rSO2 will be maintained at or above 90% of the baseline measurements. The intervention will be commenced within 15 seconds of the reduction in rSO2 value. |
Bilateral NIRS (Masimo, O3TM Regional Oximetry) will be used to measure rSO2 intraoperatively.
The NIRS electrodes will be placed on fronto-temporal area and baseline values of rSO2 obtained according to manufacturer's guidelines in the operating room prior to induction of anesthesia.
The NIRS screen will be concealed in the control group to ensure blinding.
|
Geen tussenkomst: Control group
Bilateral NIRS (Masimo, O3TM Regional Oximetry) will be used to measure rSO2 intraoperatively. In the control group, the cerebral oximetry monitor screen will be concealed, however, the recording will be continuous after verification of the signal strength and baseline value by an independent observer trained in cerebral oximetry application and unaware of the study design. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
A composite outcome of major end organ dysfunction
Tijdsspanne: surgery date to 6 months post surgery
|
A composite outcome will be assessed as a dichotomous outcome. (YES or NO). All components of the composite outcome will be weighted equally. They will include the following outcomes: postoperative delirium assessed with Confusion Assessment Method (CAM), Stroke assessed clinically, Transient Ischemic Attacks assessed clinically, Myocardial infarction, Pulmonary Embolism, Renal failure, Pneumonia, Atrial fibrillation, bleeding, mechanical ventilation for ≥48 hours, Major wound disruption, Surgical site infection, Sepsis, Septic shock, Systemic inflammatory response syndrome, Vascular graft failure. Frailty scale & DASI questionnaires will be administered at screening visit. Postoperative quality of recovery score (QoR-15) with be performed at baseline, POD 1 & 5 (discharge if earlier)]. Disability Free Survival (DFS) at 6 months (WHODAS). |
surgery date to 6 months post surgery
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 16-5747
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Chirurgie
-
Tufts Medical CenterRespiratory Motion, Inc.VoltooidMonitoring voor Low Minute Ventilation Post SurgeryVerenigde Staten
-
University of California, San FranciscoE-DA HospitalBeëindigdFarmacokinetiek van statines Pre en Post Gastric Bypass SurgeryVerenigde Staten, Taiwan
-
Europainclinics z.ú.Brno University Hospital; Pavol Jozef Safarik University; Slovak Academy of SciencesVoltooid
-
Universitair Ziekenhuis BrusselMedtronicVoltooidFailed Back Surgery SyndroomBelgië
-
Universitair Ziekenhuis BrusselMedtronicVoltooidFailed Back Surgery SyndroomBelgië
-
Fundación Universidad Católica de Valencia San...Instituto de Investigación Biomédica de SalamancaNog niet aan het wervenFailed Back Surgery SyndroomSpanje
-
Assiut UniversityNog niet aan het wervenFailed Back Surgery Syndroom
-
Centre Hospitalier Universitaire de NiceNog niet aan het werven
-
Poitiers University HospitalVoltooid
-
Boston Scientific CorporationBeëindigdPijn | Rugpijn | Failed Back Surgery SyndroomVerenigde Staten, Verenigd Koninkrijk, Canada, Frankrijk